Close Menu

Cellular Dynamics International

The partners will offer drug discovery services based on human induced pluripotent stem cells and cells derived from these.

The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.

Under the terms of the deal, Stemcell will distribute Cellular Dynamics' iCell line of induced pluripotent stem cell products.

The Madison, Wisconsin-based firm, a subsidiary of Fujifilm, will supply iCell products to Roche for use in drug discovery.

SeouLin Bioscience will distribute the company's cell line products in the Republic of Korea, and provide first-level technical support for local customers.

The deal was completed on May 1, following the expiration of a tender offer in which Cellular Dynamics' shareholders tendered 90 percent of the company's common stock. 

The deal marries Cellular Dynamics' human cell line manufacturing with Fujifilm's recombinant peptide cell scaffolding offerings.

The increase in revenues was driven by stem cell banking contracts and sales of iCell Hepatocytes.

NEW YORK (GenomeWeb) – Cellular Dynamics International today reported that its third quarter revenues increased 44 percent year over year.

NEW YORK (GenomeWeb) – Cellular Dynamics International today announced a $1.2 million contract from the National Eye Institute to manufacture stem cells for use in the development of a new potential treatment for dry age-related macular degeneration.

Pages

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.